Susan VanMeter

Susan VanMeter is currently the Executive Medical Director at UCB, Inc. They previously served as the Executive Medical Director at Zogenix, Inc., and held the position of Senior Director in Clinical Research at Mallinckrodt Pharmaceuticals from 2015 to 2021. Prior to that, they worked at GlaxoSmithKline as a Physician Project Leader and later as Senior Director of Clinical Development and Medical Affairs from 2003 to 2015. Susan also directed the Mood Disorders Program at Duke University Medical Center from 1998 to 2003, where they developed and led a multidisciplinary team for outpatient evaluations and treatments. They completed their residency in Psychiatry and Behavioral Sciences at Duke University School of Medicine from 1992 to 1995.